Financial News
DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)
3.490
+0.020
(+0.58%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Apr 17, 2025
Add to My Watchlist
Price and Volume
Detailed QuoteVolume | 419 |
Open | 3.490 |
Bid (Size) | 3.340 (2) |
Ask (Size) | 3.690 (8) |
Prev. Close | 3.470 |
Today's Range | 3.490 - 3.490 |
52wk Range | 2.140 - 6.818 |
Shares Outstanding | 37,953,711 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Earnings Scheduled For March 17, 2025
March 17, 2025
Earnings Scheduled For November 13, 2024
November 13, 2024
Preview: DiaMedica Therapeutics's Earnings
November 12, 2024
DiaMedica Therapeutics Upcoming Conference Participation
September 04, 2024
Frequently Asked Questions
Is DiaMedica Therapeutics Inc. - Common Stock publicly traded?
Yes, DiaMedica Therapeutics Inc. - Common Stock is publicly traded.
What exchange does DiaMedica Therapeutics Inc. - Common Stock trade on?
DiaMedica Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DiaMedica Therapeutics Inc. - Common Stock?
The ticker symbol for DiaMedica Therapeutics Inc. - Common Stock is DMAC on the Nasdaq Stock Market
What is the current price of DiaMedica Therapeutics Inc. - Common Stock?
The current price of DiaMedica Therapeutics Inc. - Common Stock is 3.490
When was DiaMedica Therapeutics Inc. - Common Stock last traded?
The last trade of DiaMedica Therapeutics Inc. - Common Stock was at 04/17/25 09:30 AM ET
What is the market capitalization of DiaMedica Therapeutics Inc. - Common Stock?
The market capitalization of DiaMedica Therapeutics Inc. - Common Stock is 132.46M
How many shares of DiaMedica Therapeutics Inc. - Common Stock are outstanding?
DiaMedica Therapeutics Inc. - Common Stock has 132M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.